Help your customers and vendors with independent assurance on your AI marketplace
Build successful customer relationships with unlimited use of Aival evaluation and monitoring solutions for a flat annual fee.
As an industry we need to build trust and transparency with healthcare providers fast. We believe the best way to do this is to make independent assurance available to as many as possible - as easily as possible.
Pre-sales evaluation
Enable new sites to test out products on your platform before subscribing
Local validation and selection
Let customers evaluate and compare different products on their own scans and clinical workflows
Post-deployment monitoring
Ensure ongoing effectiveness and compliance of AI once in use on patients
Compliance clarified.
Incoming regulations place obligations on both deployers and developers of AI. Aival can help fulfil these while accelerating product feedback loops by standardising monitoring processes and documentation.
FDA Guidance for Developers of AI-Enabled Medical Devices XI
Manufacturers should proactively monitor, identify, and address device performance changes
EU AI Act Article 72
Providers shall establish and document a post-market monitoring system which should actively and systematically collect, document and analyse relevant data
The Medical Devices (Post-Market Surveillance Requirements) (Amendment) (Great Britain) Regulations
Came into effect 16 June 2025
Assured by Aival.
With AI products properly validated at the local site, customers can be confident in their purchases and in satisfying their regulatory obligations.